UK-based CPH2 has entered into an agreement with Bentec an operating company entity of Kenera Energy Solutions.
The agreement brings together CPH2’s innovative membrane-free electrolyser (MFE) technology, which uses cryogenics to separate oxygen from hydrogen, and Kenera’s international client base and manufacturing capabilities.
Kenera is a newly formed business unit within leading drilling, engineering and technology company KCA Deutag Group.
Kenera has been formed as the platform from which the KCA Deutag Group shall grow its offering within hydrocarbon and energy transition markets and is a significant investor in CPH2.
The licensing arrangements, which will be effective for a period of 10 years following the completion of the manufacture of an initial 30 MFE units, are a validation of the company’s intellectual property strategy, which allows CPH2 to offer proprietary technology to manufacturing partners.
Jon Duffy, CEO of CPH2, said: “I am particularly pleased to have additionally signed two sales licensing sub-agreements, which are a capital efficient production method for CPH2, and should will enable a much faster scale up and market penetration of our innovative and disruptive hydrogen electrolyser technology. Interest in this technology continues to grow and our pipeline of opportunities is constantly developing.”
Ally Hogg, head of commercial for Kenera, commented: “This collaboration follows our investment into this exciting and ambitious high growth hydrogen business.
“The relationship with CPH2 adds to our clean energy portfolio and we look forward to actively collaborating with their team as we expand our business in the energy transition space and create value for our stakeholders by delivering our innovative technological solutions, manufacturing and after-sales expertise.”
CPH2 signs agreement with KCA Deutag Group
